BREAKING NEWS

US revokes approval of Avastin for breast cancer

By REUTERS

NOVEMBER 18, 2011 21:33

WASHINGTON - US drug regulators withdrew their approval of Roche's Avastin for breast cancer, saying the drug was not effective enough to justify its risks even if patients believe it has helped them live longer.

Reversing course on a drug that was approved for the disease in 2008, US Food and Drug Administration Commissioner Margaret Hamburg said subsequent research did not confirm hopes that Avastin would help patients with advanced breast cancer live longer or improve quality of life.

The drug will remain on the market for other uses, such as treating types of colon, lung, kidney and brain cancer.

"This was a difficult decision," Hamburg said. "With so much at stake, patients and their doctors count on the FDA to ensure the drugs they use have been shown to be safe and effective for their intended use. Sometimes, the results of rigorous testing can be disappointing."

113 people died in floods in Brazil's Rio Grande do Sul

By REUTERS

05/10/2024 03:29 PM

Anti-tank missile from Lebanon hits house in Misgav Am - report

By JERUSALEM POST STAFF

05/10/2024 02:14 PM

12 soldiers stung by hornets in southern Gaza Strip

By JERUSALEM POST STAFF

05/10/2024 01:58 PM

UKMTO receives a report of an incident 195 nm east of Yemen's Aden

By REUTERS

05/10/2024 09:31 AM